Skip to content

Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries

Efficacy of Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07272577
Enrollment
50
Registered
2025-12-09
Start date
2025-12-10
Completion date
2026-04-01
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erector Spinae Plane Block, Laparoscopic Abdominal Surgeries, Postoperative Analgesia

Brief summary

This study aims to evaluate the efficacy of the erector spinae plane block (ESPB) on postoperative analgesia in patients undergoing laparoscopic abdominal surgeries.

Detailed description

Laparoscopic surgery is associated with less pain, fewer wound infections, reduced hospital stay, reduced morbidity and mortality, and early return to work and improved overall quality of life. The role of ESPB as a better analgesic modality in reducing 24-hour opioid consumption has recently been established for post-operative analgesia in breast surgeries, video-assisted thoracoscopic surgery, and cardiothoracic surgeries.

Interventions

OTHERErector spinae plane block

Patients will receive an ultrasound-guided erector spinae plane block.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I-II. * Body mass index (BMI) between 20-30 kg/m2. * Patients undergoing laparoscopic abdominal surgeries under general anesthesia.

Exclusion criteria

* Bleeding or coagulation disorders. * Having local sepsis, pre-existing. * Peripheral neuropathies. * Chronic pain conditions. * Having any contraindication to regional anesthesia administration. * Opioid dependency. * Hypertension. * Uncontrolled diabetes mellitus.

Design outcomes

Primary

MeasureTime frameDescription
Time to the 1st rescue analgesia24 hours postoperativelyTime to the first request for the rescue analgesia (time from the end of surgery to first dose of morphine administrated).

Secondary

MeasureTime frameDescription
Total morphine consumption24 hours postoperativelyRescue analgesia of morphine will be given as 3 mg bolus if the Visual Analogue Scale (VAS) \> 3 to be repeated after 30 min if pain persists until the VAS \< 4.
Mean arterial pressureTill the end of surgery (Up to 2 hours)Mean arterial pressure will be recorded before skin incision, one minute after skin incision and then recorded regularly every 10 minutes.
Heart rateTill the end of surgery (Up to 2 hours)Heart rate will be recorded before skin incision, one minute after skin incision and then recorded regularly every 10 minutes.
Degree of pain24 hours postoperativelyEach patient will be instructed about postoperative pain assessment with the Visual Analogue Scale (VAS). VAS (0 represents no pain while 10 represents the worst pain imaginable). VAS will be assessed at 0, 4, 6, 8, 12, and 24 h postoperatively.
Incidence of adverse events24 hours postoperativelyIncidence of adverse events such as bradycardia, hypotension, nausea, vomiting, respiratory depression, or any other complication were recorded.

Countries

Egypt

Contacts

Primary ContactBahaa G Saad, MD
bahaagamal@aun.edu.eg00201555590977

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026